TCIRG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.237000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.615800E-01
Normal-vs-Stage2
4.245000E-01
Normal-vs-Stage3
7.151800E-01
Normal-vs-Stage4
3.036000E-01
Stage1-vs-Stage2
1.745430E-01
Stage1-vs-Stage3
5.013000E-01
Stage1-vs-Stage4
5.389200E-01
Stage2-vs-Stage3
9.854000E-01
Stage2-vs-Stage4
8.072000E-02
Stage3-vs-Stage4
3.594200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.859400E-01
Normal-vs-AfricanAmerican
3.454600E-01
Normal-vs-Asian
8.986000E-01
Caucasian-vs-AfricanAmerican
5.622600E-01
Caucasian-vs-Asian
2.078100E-02
AfricanAmerican-vs-Asian
7.248400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.466200E-01
Normal-vs-Female
3.209400E-01
Male-vs-Female
9.192600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.929600E-01
Normal-vs-Age(41-60Yrs)
3.051400E-01
Normal-vs-Age(61-80Yrs)
3.710800E-01
Normal-vs-Age(81-100Yrs)
3.796600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.963800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.034600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.275400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.147000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.368200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.453400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.985000E-01
Normal-vs-Daily Drinker
8.706200E-01
Normal-vs-Weekly Drinker
8.430200E-01
Normal-vs-Occasional Drinker
4.594600E-01
Normal-vs-Social Drinker
5.064600E-01
Non Drinker-vs-Daily Drinker
2.018200E-01
Non Drinker-vs-Weekly Drinker
2.503200E-01
Non Drinker-vs-Occasional Drinker
6.013600E-01
Non Drinker-vs-Social Drinker
7.571800E-01
Daily Drinker-vs-Weekly Drinker
9.556000E-01
Daily Drinker-vs-Occasional Drinker
1.765440E-01
Daily Drinker-vs-Social Drinker
2.622800E-01
Weekly Drinker-vs-Occasional Drinker
2.370400E-01
Weekly Drinker-vs-Social Drinker
3.165400E-01
Occasional Drinker-vs-Social Drinker
8.464000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.328200E-01
Normal-vs-Grade 2
6.966600E-01
Normal-vs-Grade 3
7.095000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.804900E-04
Grade 1-vs-Grade 3
2.078100E-03
Grade 1-vs-Grade 4
5.328200E-01
Grade 2-vs-Grade 3
8.128800E-01
Grade 2-vs-Grade 4
6.966600E-01
Grade 3-vs-Grade 4
7.095000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.931000E-01
Normal-vs-NonDiabetic
4.163800E-01
Diabetic-vs-NonDiabetic
7.749400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.072200E-01
Normal-vs-NoPancreatitis
2.927400E-01
Pancreatitis-vs-NoPancreatitis
4.359700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.750800E-01
Normal-vs-N1
3.100400E-01
N0-vs-N1
7.020800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.262600E-01
Normal-vs-TP53-NonMutant
5.347900E-02
TP53-Mutant-vs-TP53-NonMutant
1.54227999999978E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
